Source: Experimental Neurology. Unidade: IQ
Subjects: ARTÉRIA CEREBRAL MÉDIA, PROTEÍNAS QUINASES
ABNT
CAVALCANTE, Daniel Pereira et al. GlyT1 inhibition promotes neuroprotection in the middle cerebral artery occlusion model through the activation of GluN2A-containing NMDAR. Experimental Neurology, v. 383, p. 1-13 art. 115006, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.expneurol.2024.115006. Acesso em: 09 nov. 2024.APA
Cavalcante, D. P., Nunes, A. Í. dos S., Silva, E. R. da, Carvalho, G. A. de, Chiareli, R. A., Lima, O. C. O., et al. (2025). GlyT1 inhibition promotes neuroprotection in the middle cerebral artery occlusion model through the activation of GluN2A-containing NMDAR. Experimental Neurology, 383, 1-13 art. 115006. doi:10.1016/j.expneurol.2024.115006NLM
Cavalcante DP, Nunes AÍ dos S, Silva ER da, Carvalho GA de, Chiareli RA, Lima OCO, Leoncini GO, Ulrich H, Gomez RS, Pinto MCX. GlyT1 inhibition promotes neuroprotection in the middle cerebral artery occlusion model through the activation of GluN2A-containing NMDAR [Internet]. Experimental Neurology. 2025 ; 383 1-13 art. 115006.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.expneurol.2024.115006Vancouver
Cavalcante DP, Nunes AÍ dos S, Silva ER da, Carvalho GA de, Chiareli RA, Lima OCO, Leoncini GO, Ulrich H, Gomez RS, Pinto MCX. GlyT1 inhibition promotes neuroprotection in the middle cerebral artery occlusion model through the activation of GluN2A-containing NMDAR [Internet]. Experimental Neurology. 2025 ; 383 1-13 art. 115006.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.expneurol.2024.115006